TRPV1: a new target for treatment of visceral pain in IBS?
Holzer
Peter
P
Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Universitätsplatz 4, A-8010 Graz, Austria. peter.holzer@meduni-graz.at
D015746:Abdominal Pain / Q000188:drug therapy* / Q000378:metabolism; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy* / Q000378:metabolism; D050916:TRPV Cation Channels / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000502:physiology
D005765:Gastrointestinal Agents; D050916:TRPV Cation Channels; C494482:TRPV1 protein, human